{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:30:08Z","timestamp":1792114208567,"version":"4.4.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Depressive symptoms are common in neuropsychiatric disorders, significantly affecting quality of life and posing challenges to treatment. While pharmacological and psychological therapies remain standard, many patients show limited response. Fecal microbiota transplantation (FMT), which aims to restore gut microbial balance, has emerged as a novel approach for alleviating depressive symptoms by modulating the gut-brain axis. This study aims to conduct a comprehensive synthesis and quantitative evaluation of current evidence to elucidate the therapeutic potential of FMT in the management of depressive symptomatology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following PRISMA guidelines, we conducted a systematic search across PubMed, Embase, Web of Science, the Cochrane Library, and CINAHL from January 1, 2000, to December 31, 2024. 12 randomized controlled trials (RCTs) with 681 participants were included. The standardized mean difference (SMD) was calculated to evaluate FMT\u2019s effect on depressive symptoms. Subgroup analyses examined effects by delivery routes, follow-up duration, and clinical population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      FMT significantly reduced depressive symptoms (SMD = -1.21; 95% CI: -1.87 to -0.55;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0003). Sensitivity analysis confirmed statistical significance (SMD = -0.56; 95% CI: -0.86 to -0.26;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001). Both oral capsule and direct gastrointestinal administration were effective, with greater effects seen in direct gastrointestinal delivery (SMD = -1.06 vs. -1.29). Improvements were most notable in the short- to mid-term; effects diminished by 6 months. Subgroup analysis showed stronger effects in patients with irritable bowel syndrome (IBS) (SMD = -1.06) than in those with neurological\/psychiatric-related conditions (SMD = -0.67), with moderate heterogeneity (I\u00b2 = 47%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This meta-analysis supports FMT as an effective adjunctive therapy for depressive symptoms, especially in individuals with IBS. Endoscopic or enema routes appear more efficacious than oral capsules. While short- and mid-term benefits are evident, sustained effects require further investigation through long-term, high-quality RCTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:uri>\n                      , identifier CRD42025638185.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1656969","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:53:15Z","timestamp":1759747995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Clinical efficacy of fecal microbiota transplantation in alleviating depressive symptoms: a meta-analysis of randomized trials"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaotao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s40263-022-00931-3","article-title":"Post-covid-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment","volume":"36","author":"Mazza","year":"2022","journal-title":"CNS Drugs"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017173","article-title":"Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis","volume":"7","author":"Wang","year":"2017","journal-title":"BMJ Open"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1176669","article-title":"Association between chronic diseases and depression in the middle-aged and older adult Chinese population \u2014 a seven-year follow-up study based on charls","volume":"1176669","author":"Zhou","year":"2023","journal-title":"Front Public Health"},{"key":"B4","unstructured":"Depressive disorder (depression)\n          \n          \n          \n          2021"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30511-X","article-title":"Prevalence of mental disorders in China: a cross-sectional epidemiological study","volume":"6","author":"Huang","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.2013.815409","article-title":"The effect of severity of depressive disorder on economic burden in a university hospital in Singapore","volume":"13","author":"Ho","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","article-title":"Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the covid-19 pandemic: a comprehensive demographic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jad.2022.04.134","article-title":"Effects of group acceptance and commitment therapy (act) on anxiety and depressive symptoms in adults: a meta-analysis","volume":"309","author":"Ferreira","year":"2022","journal-title":"J Affect Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1421490","article-title":"The gut microbiota-brain connection: insights into major depressive disorder and bipolar disorder","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14737175.2024.2438646","article-title":"The involvement of the microbiota-gut-brain axis in the pathophysiology of mood disorders and therapeutic implications","volume":"1","author":"Barbosa","year":"2024","journal-title":"Expert Rev Neurother"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.24976\/Discov.Med.202436186.125","article-title":"Research progress on mechanisms of modulating gut microbiota to improve symptoms of major depressive disorder","volume":"36","author":"Lin","year":"2024","journal-title":"Discov Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2174\/0113892010281892240116081031","article-title":"The gut microbiota and major depressive disorder: current understanding and novel therapeutic strategies","volume":"25","author":"Bahmani","year":"2024","journal-title":"Curr Pharm Biotechnol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.2573","article-title":"Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis","volume":"78","author":"Nikolova","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2020.101943","article-title":"The gut microbiota in anxiety and depression - a systematic review","volume":"83","author":"Simpson","year":"2021","journal-title":"Clin Psychol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203707","article-title":"Toward a deeper understanding of gut microbiome in depression: the promise of clinical applicability","volume":"9","author":"Liu","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/nu10121939","article-title":"Faecal short chain fatty acids profile is changed in polish depressive women","volume":"10","author":"Skonieczna-\u017bydecka","year":"2018","journal-title":"Nutrients"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1113\/JP276431","article-title":"Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations","volume":"596","author":"van de Wouw","year":"2018","journal-title":"J Physiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.44","article-title":"Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host\u2019s metabolism","volume":"21","author":"Zheng","year":"2016","journal-title":"Mol Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.15698\/mic2019.10.693","article-title":"Gut microbial metabolites in depression: understanding the biochemical mechanisms","volume":"6","author":"Caspani","year":"2019","journal-title":"Microb Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"103334","DOI":"10.1016\/j.drudis.2022.08.002","article-title":"Clinical significance and potential role of trimethylamine n-oxide in neurological and neuropsychiatric disorders","volume":"27","author":"Mudimela","year":"2022","journal-title":"Drug Discov Today"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1038\/s41467-024-47273-w","article-title":"Immunoregulatory role of the gut microbiota in inflammatory depression","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1038\/s41467-022-34502-3","article-title":"Gut microbiome-wide association study of depressive symptoms","volume":"13","author":"Radjabzadeh","year":"2022","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome iv-functional gi disorders: disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.5009\/gnl230396","article-title":"Epidemiology of disorders of the gut-brain interaction: an appraisal of the rome iv criteria and beyond","volume":"18","author":"Ray","year":"2024","journal-title":"Gut Liver"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.5056\/jnm16220","article-title":"The increased level of depression and anxiety in irritable bowel syndrome patients compared with healthy controls: systematic review and meta-analysis","volume":"23","author":"Lee","year":"2017","journal-title":"J Neurogastroenterol Motil"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-01972-w","article-title":"The neurobiology of irritable bowel syndrome","volume":"28","author":"Mayer","year":"2023","journal-title":"Mol Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.900652","article-title":"Therapeutic effect of fecal microbiota transplantation on chronic unpredictable mild stress-induced depression","volume":"12","author":"Cai","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01248-9","article-title":"Faecal microbiota transplantation from patients with depression or healthy individuals into rats modulates mood-related behaviour","volume":"11","author":"Knudsen","year":"2021","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.04.038","article-title":"The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: an open-label observational study","volume":"235","author":"Kurokawa","year":"2018","journal-title":"J Affect Disord"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1299816","article-title":"Efficacy and safety of fecal microbiota transplantation for chronic insomnia in adults: a real world study","volume":"14","author":"Fang","year":"2023","journal-title":"Front Microbiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.815422","article-title":"Fecal microbiota transplantation (fmt) as an adjunctive therapy for depression-case report","volume":"13","author":"Doll","year":"2022","journal-title":"Front Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-023-01235-z","article-title":"Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial","volume":"9","author":"Green","year":"2023","journal-title":"Pilot Feasibility Stud"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20200283","article-title":"The effect of interventions targeting gut microbiota on depressive symptoms: a systematic review and meta-analysis","volume":"9","author":"Hofmeister","year":"2021","journal-title":"Cmaj Open"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-020-02654-5","article-title":"Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review","volume":"20","author":"Chinna Meyyappan","year":"2020","journal-title":"BMC Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1416961","article-title":"Current landscape of fecal microbiota transplantation in treating depression","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12876-024-03311-x","article-title":"A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1208\/s12249-020-1637-z","article-title":"The route to palatable fecal microbiota transplantation","volume":"21","author":"Fadda","year":"2020","journal-title":"AAPS Pharmscitech"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac135","article-title":"Efficacy of fecal microbiota transplantation in the treatment of active ulcerative colitis: a systematic review and meta-analysis of double-blind randomized controlled trials","volume":"29","author":"El","year":"2023","journal-title":"Inflammation Bowel Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s40001-024-02046-5","article-title":"Clinical efficacy and safety of faecal microbiota transplantation in the treatment of irritable bowel syndrome: a systematic review, meta-analysis and trial sequential analysis","volume":"29","author":"Lo","year":"2024","journal-title":"Eur J Med Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The prisma 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2493901","article-title":"Fecal microbiota transplantation: a tale of two regulatory pathways","volume":"17","author":"Hoffmann","year":"2025","journal-title":"Gut Microbes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1159\/000540420","article-title":"Efficacy of donor-recipient-matched faecal microbiota transplantation in patients with ibs-d: a single-centre, randomized, double-blind placebo-controlled study","volume":"105","author":"Zhang","year":"2024","journal-title":"Digestion"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29812","article-title":"Fecal microbiota transplantation alleviates mild-moderate covid-19 associated diarrhoea and depression symptoms: a prospective study of a randomized, double-blind clinical trial","volume":"96","author":"Jiang","year":"2024","journal-title":"J Med Virol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2024.104535","article-title":"Fecal microbiota transplantation improves clinical symptoms of fibromyalgia: an open-label, randomized, nonplacebo-controlled study","volume":"25","author":"Fang","year":"2024","journal-title":"J Pain"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1177\/07067437221150508","article-title":"Feasibility, acceptability, and safety of faecal microbiota transplantation in the treatment of major depressive disorder: a pilot randomized controlled trial","volume":"68","author":"Green","year":"2023","journal-title":"Can J Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101888","article-title":"Efficacy of faecal microbiota transplantation in patients with progressive supranuclear palsy-richardson\u2019s syndrome: a phase 2, single centre, randomised clinical trial","volume":"58","author":"Tian","year":"2023","journal-title":"Eclinicalmedicine"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2284247","article-title":"Efficacy of fecal microbiota transplantation in patients with parkinson\u2019s disease: clinical trial results from a randomized, placebo-controlled design","volume":"15","author":"Cheng","year":"2023","journal-title":"Gut Microbes"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.33073\/pjm-2023-025","article-title":"The impacts of fecal microbiota transplantation from same sex on the symptoms of ulcerative colitis patients","volume":"72","author":"Shang","year":"2023","journal-title":"Pol J Microbiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14891","article-title":"Effect of faecal microbial transplant via colonoscopy in patients with severe obesity and insulin resistance: a randomized double-blind, placebo-controlled phase 2 trial","volume":"25","author":"Ghorbani","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1999374","article-title":"Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules","volume":"12","author":"Guo","year":"2021","journal-title":"Bioengineered"},{"key":"B53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12934-021-01720-1","article-title":"The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (ibs-d) patients with anxiety and depression behaviors","volume":"20","author":"Lin","year":"2021","journal-title":"Microb Cell Fact"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15740","article-title":"Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome","volume":"51","author":"Lahtinen","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30198-0","article-title":"Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial","volume":"4","author":"Aroniadis","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2022.2124071","article-title":"Is fecal microbiota transplantation a useful therapeutic intervention for psychiatric disorders? A narrative review of clinical and preclinical evidence","volume":"39","author":"Vasiliu","year":"2023","journal-title":"Curr Med Res Opin"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1024\/1422-4917\/a000928","article-title":"Fecal microbiota transplants in the context of (child and adolescent) psychiatric disorders","volume":"51","author":"Trinh","year":"2023","journal-title":"Z Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2023.110860","article-title":"Pick fecal microbiota transplantation to enhance therapy for major depressive disorder","volume":"128","author":"Meng","year":"2024","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2508950","article-title":"Donor-centric administration of the stool donor program is vital to its feasibility and patient safety","volume":"17","author":"Kabage","year":"2025","journal-title":"Gut Microbes"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2023.03.020","article-title":"Key determinants of success in fecal microbiota transplantation: from microbiome to clinic","volume":"31","author":"Porcari","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914562","article-title":"Fecal microbiota transplantation in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Jamshidi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9020358","article-title":"An oral fmt capsule as efficient as an enema for microbiota reconstruction following disruption by antibiotics, as assessed in an in vitro human gut model","volume":"9","author":"Verdier","year":"2021","journal-title":"Microorganisms"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1177\/2050640618780762","article-title":"Efficacy of different faecal microbiota transplantation protocols for clostridium difficile infection: a systematic review and meta-analysis","volume":"6","author":"Ianiro","year":"2018","journal-title":"United Eur Gastroenterol J"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104954","article-title":"Delivery routes for faecal microbiota transplants: available, anticipated and aspired","volume":"159","author":"Gulati","year":"2020","journal-title":"Pharmacol Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"lxad44","DOI":"10.1093\/jambio\/lxad044","article-title":"Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies","volume":"134","author":"K\u00f6rner","year":"2023","journal-title":"J Appl Microbiol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq4006","article-title":"Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis","volume":"15","author":"Halsey","year":"2023","journal-title":"Sci Transl Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071332","article-title":"Gut microbiota manipulation in irritable bowel syndrome","volume":"10","author":"Mazzawi","year":"2022","journal-title":"Microorganisms"},{"key":"B68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/bs.pbr.2023.01.003","article-title":"Neuroinflammation through the vagus nerve-dependent gut-microbiota-brain axis in treatment-resistant depression","volume":"278","author":"Hashimoto","year":"2023","journal-title":"Prog Brain Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04152-22","article-title":"Capsulized fecal microbiota transplantation induces remission in patients with ulcerative colitis by gut microbial colonization and metabolite regulation","volume":"11","author":"Chen","year":"2023","journal-title":"Microbiol Spectr"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-023-03123-1","article-title":"Multi-omics analysis of fecal microbiota transplantation\u2019s impact on functional constipation and comorbid depression and anxiety","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Microbiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2025.02.011","article-title":"Multi-omics analysis reveals mechanisms of fmt in enhancing antidepressant effects of ssris","volume":"126","author":"Jiang","year":"2025","journal-title":"Brain Behav Immun"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-024-03211-7","article-title":"The extracellular vesicle of depressive patient-derived escherichia fergusonii induces vagus nerve-mediated neuroinflammation in mice","volume":"21","author":"Ma","year":"2024","journal-title":"J Neuroinflamm"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00218-22","article-title":"Effects of \u2018healthy\u2019 fecal microbiota transplantation against the deterioration of depression in fawn-hooded rats","volume":"7","author":"Hu","year":"2022","journal-title":"Msystems"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-024-03311-x","article-title":"A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.2174\/0118715273289138240306050532","article-title":"Gastrointestinal issues in depression, anxiety, and neurodegenerative diseases: a systematic review on pathways and clinical targets implications","volume":"23","author":"Andriolo","year":"2024","journal-title":"CNS Neurological Disord - Drug Targets"},{"key":"B76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-981-97-4402-2_4","article-title":"Probiotics and fecal microbiota transplantation in major depression: doxa or episteme","volume":"1456","author":"Evrensel","year":"2024","journal-title":"Adv Exp Med Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3760\/cma.j.cn441530-20250114-00025","article-title":"Long-term efficacy analysis of fecal microbiota transplantation in 15,000 cases of gut dysbiosis-related diseases","volume":"28","author":"Yang","year":"2025","journal-title":"Chin J Gastrointest Surg"},{"key":"B78","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12866-024-03261-0","article-title":"The effect of fecal microbiota transplantation on antibiotic-associated diarrhea and its impact on gut microbiota","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Microbiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e14641","DOI":"10.1111\/nmo.14641","article-title":"Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome","volume":"36","author":"El-Salhy","year":"2024","journal-title":"Neurogastroenterol Motil"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i17.2666","article-title":"Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: a randomized controlled trial","volume":"29","author":"Lahtinen","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of rome foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2413367","article-title":"A pathophysiologic framework for the overlap of disorders of gut-brain interaction and the role of the gut microbiome","volume":"16","author":"Shah","year":"2024","journal-title":"Gut Microbes"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2360233","article-title":"The gut microbiome in disorders of gut-brain interaction","volume":"16","author":"Kraimi","year":"2024","journal-title":"Gut Microbes"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2022.05.003","article-title":"Multi-probiotics ameliorate major depressive disorder and accompanying gastrointestinal syndromes via serotonergic system regulation","volume":"45","author":"Tian","year":"2023","journal-title":"J Adv Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1631\/jzus.B2300343","article-title":"New perspectives on microbiome-dependent gut-brain pathways for the treatment of depression with gastrointestinal symptoms: from bench to bedside","volume":"26","author":"Liu","year":"2025","journal-title":"J Zhejiang Univ Sci B"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X23500854","article-title":"Chinese materia medica in treating depression: the role of intestinal microenvironment","volume":"51","author":"Shen","year":"2023","journal-title":"Am J Chin Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13079","article-title":"Long-term effects of fecal microbiota transplantation on gut microbiota after helicobacter pylori eradication with bismuth quadruple therapy: a randomized controlled trial","volume":"29","author":"Zhao","year":"2024","journal-title":"Helicobacter"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.827220","article-title":"The effects of psychological interventions on symptoms and psychology of functional dyspepsia: a systematic review and meta-analysis","volume":"13","author":"Wei","year":"2022","journal-title":"Front Psychol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2024.2368250","article-title":"The effect of mindfulness-based cognitive therapy on the clinical efficacy and psychological state in patients with functional dyspepsia","volume":"59","author":"Long","year":"2024","journal-title":"Scand J Gastroenterol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jad.2025.01.048","article-title":"Genetic correlation, pleiotropic loci and shared risk genes between major depressive disorder and gastrointestinal tract disorders","volume":"374","author":"Zhou","year":"2025","journal-title":"J Affect Disord"},{"key":"B91","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12991-024-00509-x","article-title":"Association of both depressive symptoms scores and specific depressive symptoms with all-cause and cardiovascular disease mortality","volume":"23","author":"Liu","year":"2024","journal-title":"Ann Gen Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1656969\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:53:18Z","timestamp":1759747998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1656969\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":91,"alternative-id":["10.3389\/fpsyt.2025.1656969"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1656969","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"article-number":"1656969"}}